Literature DB >> 6607069

Purification and properties of a type beta transforming growth factor from bovine kidney.

A B Roberts, M A Anzano, C A Meyers, J Wideman, R Blacher, Y C Pan, S Stein, S R Lehrman, J M Smith, L C Lamb.   

Abstract

Type beta transforming growth factor (TGF-beta) has been purified 200 000-fold from bovine kidneys. This peptide is characterized by its ability to induce anchorage-dependent normal rat kidney cells to grow in soft agar in the presence of epidermal growth factor (EGF); TGF-beta is not mitogenic for cells grown in monolayer culture. Purified TGF-beta does not compete with EGF for binding to membrane receptors. The concentration of TGF-beta required to elicit a half-maximal response for formation of colonies greater than 3100 micron2 in the soft agar assay is 2-3 pM (55 pg/mL) when assayed in the presence of 0.8 nM EGF (5 ng/mL). The four-step purification procedure which includes chromatography of acid--ethanol tissue extracts on polyacrylamide sizing gels, cation exchange, and two steps of high-pressure liquid chromatography results in a 10% overall yield of colony-forming activity with a recovery of 3-4 micrograms/kg. Amino acid analysis of purified TGF-beta shows 16 half-cystine residues per mole. Analysis of the purified polypeptide by electrophoresis on sodium dodecyl sulfate-polyacrylamide gels indicates that TGF-beta is composed of two closely related polypeptide chains cross-linked by disulfide bonds. In the absence of beta-mercaptoethanol, the colony-forming activity is associated with a single silver-staining band of molecular weight 25 000; in the presence of beta-mercaptoethanol, the TGF-beta is converted to an inactive species that migrates as a single band of molecular weight 12 500-13 000. Sequence analysis indicates that at least the first 15 N-terminal amino acids of the two TGF-beta subunits are identical.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6607069     DOI: 10.1021/bi00294a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  67 in total

1.  Extraction and purification of TGFbeta and its effect on the induction of apoptosis of hepatocytes.

Authors:  X H Si; L J Yang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

Review 3.  TGF-beta: problems and prospects.

Authors:  M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-11

Review 4.  Exercise-induced hormonal changes and their effects upon skeletal muscle tissue.

Authors:  M R Deschenes; W J Kraemer; C M Maresh; J F Crivello
Journal:  Sports Med       Date:  1991-08       Impact factor: 11.136

5.  Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.

Authors:  P A Dennis; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

6.  Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit.

Authors:  T Coimbra; R Wiggins; J W Noh; S Merritt; S H Phan
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

7.  [Growth factors. A new dimension in understanding oncogenesis].

Authors:  V Heinemann; U Jehn
Journal:  Klin Wochenschr       Date:  1985-08-16

8.  Development of a retroviral vector for inducible expression of transforming growth factor beta 1.

Authors:  M L McGeady; P M Arthur; M Seidman
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  Down-regulation of transforming growth factor beta-2 expression is associated with the reduction of cyclosporin induced gingival overgrowth in rats treated with roxithromycin: an experimental study.

Authors:  Simone Aparecida Probst Condé; Marcus Gomes Bastos; Beatriz Julião Vieira; Fernando Monteiro Aarestrup
Journal:  BMC Oral Health       Date:  2009-12-08       Impact factor: 2.757

10.  Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats.

Authors:  T F Zioncheck; S A Chen; L Richardson; M Mora-Worms; C Lucas; D Lewis; J D Green; J Mordenti
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.